C7ORF25 antibody (AA 1-100) (Biotin)
Quick Overview for C7ORF25 antibody (AA 1-100) (Biotin) (ABIN1701198)
Target
Reactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 1-100
-
Cross-Reactivity
- Mouse
-
Predicted Reactivity
- Human,Rat,Dog,Cow,Sheep,Pig,Horse,Rabbit
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human C7orf25
-
Isotype
- IgG
-
-
-
-
Application Notes
-
WB 1:300-5000
IHC-P 1:200-400
IHC-F 1:100-500 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Store at -20°C for 12 months.
-
Expiry Date
- 12 months
-
-
- C7ORF25 (Chromosome 7 Open Reading Frame 25 (C7ORF25))
-
Alternative Name
- C7orf25
-
Background
-
Synonyms: C7orf25, CG025_HUMAN, Chromosome 7 open reading frame 25, RGD1308147, UPF0415 protein C7orf25.
Background: Chromosome 7 has been linked to Osteogenesis imperfecta, Pendred syndrome, Lissencephaly, Citrullinemia and Shwachman-Diamond syndrome. The deletion of a portion of the q arm of chromosome 7 is associated with Williams-Beuren syndrome, a condition characterized by mild mental retardation, an unusual comfort and friendliness with strangers and an elfin appearance. Deletions of portions of the q arm of chromosome 7 are also seen in a number of myeloid disorders including cases of acute myelogenous leukemia and myelodysplasia. The C7orf25 gene product has been provisionally designated C7orf25 pending further characterization.
Target
-